The Ministry of health has registered another Drug for the treatment COVID-19.
As informs a press-service Agency, registration card received the Drug "Levelmap" (trade name of "Alcira" ).
"The drug is indicated for patients with severe disease develops when the so-called cytokine storm - an excessive inflammatory reaction to the introduction of the virus, which causes damage to tissues and organs, such as lung tissue, to a severe course of the infection which may be fatal," according to the report.
"Levelmap" produces biotech Firm Biocad. This is an original Patriotic inhibitor of interleukin-6. As can be seen from the provisional methodological recommendations of the Ministry of health for the prevention, diagnosis and treatment coronavirus infection, the mortality rate is COVID-19 are also associated with increased levels of interleukin-6. From the beginning, the Drug was developed to treat rheumatoid arthritis.
Pandemic coronavirus infection COVID-19 embraced in practice by the whole world. According to the final data to who, there are over six and a half million infected, 387 thousand of them died.
in Russia the number of cases of infection with coronavirus exceeded 458 million, more than 5, 7 thousand people died, more than 220 thousand recovered.
Current information on the situation of COVID-19 in Russia and the world presented on the portal stopmanager. Of the Russian Federation.
<span style="color:darkgray
sections: Politics |